{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:45:28Z","timestamp":1793497528363,"version":"4.5.0"},"reference-count":46,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T00:00:00Z","timestamp":1079568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:p><jats:bold>Abstract\u2003<\/jats:bold>Pemphigus is an autoimmune skin disease that can present in a variety of forms and can be a challenging disease to manage and treat. An overview of the different forms of pemphigus and diagnostics are discussed including pemphigus foliaceus (PF), pemphigus erythematosus (PE), panepidermal pustular pemphigus (PPP), pemphigus vulgaris (PV) and paraneoplastic pemphigus (PNP). Emphasis on therapy is presented. Included are the most current commonly used therapeutics (glucocorticoids, azathioprine, chlorambucil and tetracycline and niacinamide); current alternative therapeutics (cyclosporin and tacrolimus and mycophenolate mofetil) and additional alternative therapeutics (cyclophosphamide, chrysotherapy, dapsone, sulfasalazine and intravenous immunoglobulin (IVIG) therapy).<\/jats:p>","DOI":"10.1111\/j.1365-3164.2004.00360.x","type":"journal-article","created":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T12:25:28Z","timestamp":1079612728000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pemphigus: current therapy"],"prefix":"10.1111","volume":"15","author":[{"given":"Wayne S.","family":"Rosenkrantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,3,18]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"321","volume-title":"Advances in Veterinary Dermatology III","author":"Suter M.M.","year":"1998"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70145-3"},{"key":"e_1_2_8_4_2","unstructured":"Suter M.M. De Bruin A. Wurm S.et al.Bullous autoimmune skin diseases in animals.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists1997;100\u20133."},{"key":"e_1_2_8_5_2","first-page":"141","volume-title":"Current Veterinary Dermatology","author":"Rosenkrantz W.S.","year":"1993"},{"key":"e_1_2_8_6_2","unstructured":"Carlotti D.N.et al.Pemphigus vulgaris in the dog. A report of 8 cases.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists1999;15\u201321."},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(94)90218-6"},{"key":"e_1_2_8_8_2","unstructured":"Walder E.J.Werner A.A possible paraneoplastic skin disease with features of erythema multiforme and pemphigus foliaceus in a dog.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists1996:70."},{"key":"e_1_2_8_9_2","first-page":"678","volume-title":"Small Animal Dermatology","author":"Scott D.W.","year":"2001"},{"key":"e_1_2_8_10_2","first-page":"279","volume-title":"Immunologic Diseases of the Skin","author":"Dugan E.M.","year":"1991"},{"key":"e_1_2_8_11_2","first-page":"654","volume-title":"Fitzpatrick's Dermatology in General Medicine V.","author":"Stanley J.R.","year":"1999"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12456932"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01099.x"},{"key":"e_1_2_8_14_2","unstructured":"Griffin C.E.Pemphigus foliaceus: recent findings on the pathophysiology and results of treatment. Presentation William Dick Bicentenary Edinburgh 1993."},{"key":"e_1_2_8_15_2","unstructured":"Iwasaki T. Maeda Y.The effect of ultraviolet (UV) on the severity of canine pemphigus erythematosus.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists1997:86."},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90167-1"},{"key":"e_1_2_8_17_2","unstructured":"Iwasaki T. Shimizu M. Obata H.The detection of the autoantigen targeted by patient sera from dogs with pemphigus foliaceus.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists1996:44."},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12317587"},{"key":"e_1_2_8_19_2","unstructured":"Crameri F.M. Suter M.M.Induction of acantholysis in a serum\u2010free culture system.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists1994:63."},{"key":"e_1_2_8_20_2","first-page":"367","volume-title":"Advances in Veterinary Dermatology","author":"Suter M.M.","year":"1993"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12283762"},{"key":"e_1_2_8_22_2","first-page":"424","article-title":"Immune\u2010mediated dermatoses in domestic animals ten years after \u2013 Part I","volume":"9","author":"Scott D.W.","year":"1987","journal-title":"Compendium of Continuing Education for the Practicing Veterinarian"},{"key":"e_1_2_8_23_2","unstructured":"Gomez S.M. Morris D.O. Goldschmidt M.H.Factors affecting mortality or survival in dogs with pemphigus foliaceus. A retrospective analysis of 43 dogs.Proceedings of the Annual Members\u2019 Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists2002:34."},{"key":"e_1_2_8_24_2","first-page":"329","article-title":"Adrenocortical suppression associated with topical otic administration of glucocorticoids in dogs","volume":"193","author":"Moriello K.A.","year":"1988","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_25_2","first-page":"481","volume-title":"Advances in Veterinary Dermatology III","author":"Verheijen F.","year":"1998"},{"key":"e_1_2_8_26_2","first-page":"573","volume-title":"Kirk's Current Veterinary Therapy XII.","author":"Scott D.W.","year":"1995"},{"key":"e_1_2_8_27_2","first-page":"2783","volume-title":"Fitzpatrick's Dermatology in General Medicine V","author":"Werth V.P.","year":"1999"},{"key":"e_1_2_8_28_2","first-page":"570","volume-title":"Current Veterinary Therapy X","author":"Rosenkrantz W.S.","year":"1989"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2460\/javma.1992.200.10.1497","article-title":"Use of tetracycline and niacinamide for the treatment of autoimmune skin disease in 20 dogs","volume":"200","author":"White S.D.","year":"1992","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_30_2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archderm.1986.01660180076019","article-title":"The treatment of bullous pemphigoid with tetracycline and niacinamide","volume":"122","author":"Berk M.A.","year":"1986","journal-title":"Archives of Dermatology"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01922409"},{"key":"e_1_2_8_32_2","first-page":"3272","article-title":"Modes of action of FK506, cyclosporine A and rapamycin","volume":"26","author":"Morris R.","year":"1994","journal-title":"Transplant Proceedings"},{"key":"e_1_2_8_33_2","first-page":"3082","article-title":"Role of cyclosporine. Present and future","volume":"26","author":"Kahan B.D.","year":"1994","journal-title":"Transplant Proceedings"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90111-J"},{"key":"e_1_2_8_35_2","first-page":"377","article-title":"Clinical evaluation of cyclosporine in animal models with cutaneous immune\u2010mediated disease and epitheliotrophic lymphoma","volume":"25","author":"Rosenkrantz W.S.","year":"1989","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_8_36_2","doi-asserted-by":"crossref","unstructured":"Griffies J.D. Mendelsohn C.L. Rosenkrantz W.S.et al.Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus Journal of the American Animal Hospital Association2004;40:29\u201341.","DOI":"10.5326\/0400029"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198610000-00012"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/52.14.1521"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00309052"},{"key":"e_1_2_8_40_2","unstructured":"Byrne K. Morris D.O.Study to determine the usefulness of Mycophenolate mofetil (MMF) for the treatment of pemphigus foliaceus in the dog.Proceedings of the 16th Annual American Academy of Veterinary Dermatology and the American College of Veterinary Dermatology Meeting 2001."},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90231-7"},{"key":"e_1_2_8_42_2","first-page":"2","article-title":"Oral gold therapy","volume":"5","author":"White S.","year":"1986","journal-title":"Dermatology Dialogue"},{"key":"e_1_2_8_43_2","first-page":"636","volume-title":"Kirk's Current Veterinary Therapy XII","author":"Kummel B.A.","year":"1995"},{"key":"e_1_2_8_44_2","first-page":"606","volume-title":"Current Veterinary Therapy IX","author":"Scott D.W.","year":"1980"},{"key":"e_1_2_8_45_2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2460\/javma.1997.210.11.1623","article-title":"Intravenous administration of human immune globulin in dogs with immune\u2010mediated hemolytic anemia","volume":"210","author":"Scott\u2010Moncrieff J.C.","year":"1997","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.112325"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.116339"}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3164.2004.00360.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3164.2004.00360.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T18:33:28Z","timestamp":1705084408000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3164.2004.00360.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,18]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1111\/j.1365-3164.2004.00360.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3164.2004.00360.x","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,18]]},"assertion":[{"value":"2004-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}